Revance Therapeutics, Inc. Annual Return On Equity in % from 2014 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Revance Therapeutics, Inc. quarterly/annual Return On Equity history and growth rate from 2014 to 2023.
  • Revance Therapeutics, Inc. Return On Equity for the quarter ending September 30, 2024 was 136 %, a 92.3% decline year-over-year.
  • Revance Therapeutics, Inc. annual Return On Equity for 2023 was 503 %.
  • Revance Therapeutics, Inc. annual Return On Equity for 2022 was -787 %, a 333% decline from 2021.
  • Revance Therapeutics, Inc. annual Return On Equity for 2021 was -182 %, a 111% decline from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 503 +1.29K Jan 1, 2023 Dec 31, 2023
2022 -787 -605 -333% Jan 1, 2022 Dec 31, 2022
2021 -182 -95.7 -111% Jan 1, 2021 Dec 31, 2021
2020 -86.1 -4.96 -6.12% Jan 1, 2020 Dec 31, 2020
2019 -81.1 -7.43 -10.1% Jan 1, 2019 Dec 31, 2019
2018 -73.7 -9.26 -14.4% Jan 1, 2018 Dec 31, 2018
2017 -64.4 -21.4 -49.8% Jan 1, 2017 Dec 31, 2017
2016 -43 -1.48 -3.57% Jan 1, 2016 Dec 31, 2016
2015 -41.5 -2.28 -5.81% Jan 1, 2015 Dec 31, 2015
2014 -39.2 Jan 1, 2014 Dec 31, 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.